This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:addisons [12.02.2018] – [Patient's remarks] sallieq | home:diseases:addisons [01.15.2019] – [Patient's reports] sallieq | ||
---|---|---|---|
Line 2: | Line 2: | ||
====== Addison' | ====== Addison' | ||
+ | |||
+ | ===== Introduction ===== | ||
+ | |||
[[http:// | [[http:// | ||
Line 15: | Line 18: | ||
===== Evidence of infectious cause ===== | ===== Evidence of infectious cause ===== | ||
- | ===== Patient' | + | ===== Recent research ===== |
+ | |||
+ | Even though efficient and safe pharmaceutical preparations for the substitution of endogenous gluco- and mineralocorticoids are established in therapy, the mortality in patients with primary adrenal insufficiency (PAI) is still increased and the health-related quality of life (HRQoL) is often reduced. PAI is a rare disease but recent data report an increasing prevalence. In addition to the common " | ||
+ | |||
+ | Acute adrenal crisis is a life-threatening condition that requires immediate treatment. Standard replacement therapy consists of multiple daily doses of hydrocortisone or cortisone acetate combined with fludrocortisone. Annual follow-up by an endocrinologist is recommended with the focus on optimization of replacement therapy and detection of new autoimmune diseases. | ||
+ | |||
+ | |||
+ | The most common causes of PAI are autoimmune adrenalitis (Addison' | ||
+ | |||
+ | Main presenting symptoms of Addison' | ||
+ | |||
+ | New-onset autoimmune Addison' | ||
+ | |||
+ | The prevalence of the metabolic syndrome in patients with AM was 35.71% after a period of treatment longer than 15 years. (({{pubmed> | ||
+ | ===== Patient' | ||
Amelia < | Amelia < | ||
Line 31: | Line 48: | ||
- | Sample PubMed cite(({{pubmed> | ||
- | {{tag> | ||
- | < | + | {{tag>Diseases arrange}} |
+ | |||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
+ | |||
+ | |||
+ | look in | ||
+ | |||
+ | GETCONTENT | ||
+ | |||
+ | * legacy content | ||
+ | * | ||
===== Symptoms ===== | ===== Symptoms ===== | ||
Line 50: | Line 75: | ||
===== Patient interviews ===== | ===== Patient interviews ===== | ||
===== Presentations and publications===== | ===== Presentations and publications===== | ||
- | |||
- | |||
- | GETCONTENT | ||
- | |||
- | * legacy content | ||
- | * | ||
- | |||
- | |||
===== References ===== | ===== References ===== |